Home
Subjects
blood cells

blood cells

Accelerating Immune Research with Cryopreserved Peripheral Blood Mononuclear Cells

The Scientist’s Creative Services Team and MilliporeSigma | Jul 18, 2022 | 3 min read

Commerically-available peripheral blood mononuclear cells offer a well-characterized, accessible, and consistent model for immunology and therapeutic development.

Walter Gratzer, Biophysical Chemist and Science Writer, Dies at 89

Chloe Tenn | Nov 23, 2021 | 2 min read

His career bridged impactful research in molecular biology and biochemistry with prolific science writing for academic and nonacademic audiences alike.

LabTalk Podcast - Hijacking Genes: Uncovering the Cause of Lineage Ambiguous Leukemia

The Scientist’s Creative Services Team | Oct 28, 2021 | 1 min read

Chromosomal rearrangements reposition influential and often overlooked non-coding elements in the genome to hijack genes and cause cancer.

Red blood cells are pictured in grayscale on a gray background

Red Blood Cells Activate Innate Immune System

Abby Olena, PhD | Oct 20, 2021 | 4 min read

Researchers link the ability of the cells to bind and present DNA from pathogens and cell death to anemia, which is common in COVID-19, and immune activation.

Defined Primary Cell Culture and Media

The Scientist Creative Services Team in collaboration with MilliporeSigma | Jul 29, 2021 | 3 min read

A new partnership opens the door for a source of highly purified human primary cells and defined cell culture media.

Multiomic Single-Cell Analysis Identifies a Unique Stem and Progenitor Population

The Scientist’s Creative Services Team | Jul 14, 2020 | 2 min read

Margaret Nakamoto will introduce the BD Rhapsody™ Single-Cell Analysis System, and Ravi Majeti will discuss how he and his team used concurrent RNA and BD® AbSeq Antibody-oligo multiplexed surface marker analysis to improve HSPC clustering and characterize specific phenotypic states along unique hematopoietic differentiation trajectories.

Early Results Are Positive for Experimental CRISPR Therapies

Jef Akst | Nov 19, 2019 | 2 min read

Two clinical trial participants—one with β-thalassemia and one with sickle cell disease—appeared to benefit from the gene-editing treatments with minimal side effects, according to the companies.

In Our Blood: A Profile of Stuart Orkin

Anna Azvolinsky | Jul 15, 2019 | 9 min read

By unraveling the molecular underpinnings of inherited blood disorders, the Boston Children’s Hospital researcher has provided the basis for therapies now being tested for beta-thalassemia and sickle cell disease.